chloroquine has been researched along with Preterm Birth in 4 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among pregnancies exposed to 4-aminoquinolines (chloroquine and HCQ), no increased risk of major birth defects, preterm birth, or SGA was identified." | 8.02 | Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study. ( Andersen, JT; Andersson, NW; Skov, L, 2021) |
| "Malaria chemoprophylaxis options in pregnancy are limited, and atovaquone-proguanil (AP) is not recommended because of insufficient safety evidence." | 7.88 | A survey on outcomes of accidental atovaquone-proguanil exposure in pregnancy. ( Fairley, JK; Gutman, JR; Tan, KR; Wang, M, 2018) |
| "Until late 2015, Botswana recommended preventive treatment for pregnant women in malarial regions with chloroquine and proguanil (CP)." | 4.12 | Impact of prophylactic antimalarials in pregnant women living with Human Immunodeficiency Virus on birth outcomes in Botswana. ( Diseko, M; Lockman, S; Mabuta, J; Makhema, J; Mayondi, G; Melton, ML; Mmalane, M; Olaleye, OA; Shapiro, RL; Zash, R, 2022) |
| "Among pregnancies exposed to 4-aminoquinolines (chloroquine and HCQ), no increased risk of major birth defects, preterm birth, or SGA was identified." | 4.02 | Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study. ( Andersen, JT; Andersson, NW; Skov, L, 2021) |
| "Malaria chemoprophylaxis options in pregnancy are limited, and atovaquone-proguanil (AP) is not recommended because of insufficient safety evidence." | 3.88 | A survey on outcomes of accidental atovaquone-proguanil exposure in pregnancy. ( Fairley, JK; Gutman, JR; Tan, KR; Wang, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olaleye, OA | 1 |
| Zash, R | 1 |
| Diseko, M | 1 |
| Mayondi, G | 1 |
| Mabuta, J | 1 |
| Lockman, S | 1 |
| Melton, ML | 1 |
| Mmalane, M | 1 |
| Makhema, J | 1 |
| Shapiro, RL | 1 |
| Andersson, NW | 1 |
| Skov, L | 1 |
| Andersen, JT | 1 |
| Tan, KR | 1 |
| Fairley, JK | 1 |
| Wang, M | 1 |
| Gutman, JR | 1 |
| Denoeud, L | 1 |
| Fievet, N | 1 |
| Aubouy, A | 1 |
| Ayemonna, P | 1 |
| Kiniffo, R | 1 |
| Massougbodji, A | 1 |
| Cot, M | 1 |
1 trial available for chloroquine and Preterm Birth
| Article | Year |
|---|---|
Is chloroquine chemoprophylaxis still effective to prevent low birth weight? Results of a study in Benin.
Topics: Adult; Anemia; Antimalarials; Bedding and Linens; Benin; Birth Weight; Chloroquine; Drug Administrat | 2007 |
3 other studies available for chloroquine and Preterm Birth
| Article | Year |
|---|---|
Impact of prophylactic antimalarials in pregnant women living with Human Immunodeficiency Virus on birth outcomes in Botswana.
Topics: Antimalarials; Botswana; Chloroquine; Female; HIV; HIV Infections; Humans; Infant, Newborn; Malaria; | 2022 |
Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Cohort Studies; Denmark; Female; Humans; Hydroxychlor | 2021 |
A survey on outcomes of accidental atovaquone-proguanil exposure in pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Antimalarials; Atovaquone; Chemopreventio | 2018 |